Why Proper EV Storage is Critical for Research and Therapeutic Applications
Extracellular vesicles (EVs) are pivotal in biomarker discovery, drug delivery, and regenerative medicine. However, maintaining their structural integrity and biological function remains a major challenge. A recent study published in Journal of Biological Engineering highlights the critical impact of storage conditions on EV bioavailability, shedding light on the risks of EV degradation and altered cargo profiles due to suboptimal preservation.
🔬 Key Findings from the Study
- Storage Temperature Dictates EV Stability
The study demonstrates that EVs stored at non-optimized temperatures undergo membrane disruption, cargo leakage, and functional loss. Long-term storage at -80°C is common, but EV degradation still occurs without stabilizing agents.
- Freeze-Thaw Cycles Lead to Functional Decline
Repeated freeze-thaw cycles induce aggregation, vesicle rupture, and cargo instability, ultimately compromising experimental reproducibility and reducing therapeutic efficacy.
- Buffer Composition Directly Affects EV Integrity
The study reports that commonly used PBS and standard buffers fail to prevent EV clustering. Specialized storage buffers are essential to maintain particle size distribution, zeta potential, and functional bioactivity.
Implications for EV-Based Research and Therapeutics
Failure to optimize EV storage conditions leads to:
- Reduced reproducibility in proteomic and transcriptomic analyses
- Loss of therapeutic potency in drug-loaded EVs
- Altered biomarker profiles, compromising diagnostic accuracy
- Unreliable data in functional studies, leading to misleading biological interpretations
For researchers, this highlights the urgent need for standardized EV storage protocols and stabilizing solutions to ensure long-term bioactivity and translational success.
📖 Full study available here:
🔗 https://jbioleng.biomedcentral.com/articles/10.1186/s13036-024-00470-z